1)Ikeda K, et al:Effect of early fosfomycin treatment on prevention of hemolytic uremic syndrome accompanying Escherichia coli O157;H7 infection. Clin Nephrol 52:357-362, 1999
2)Freedman SB, et al:Shiga toxin-producing escherichia coli infection, antibiotics, and risk of developing hemolytic uremic syndrome;A meta-analysis. Clin Infect Dis 62:1251-1258, 2016
3)厚生労働省:食中毒統計資料. http://www.mhlw.go.jp/stf/seisakunitsuite/bunya/kenkou_iryou/shokuhin/syokuchu/04.html.(2019年3月14日閲覧)
4)Allen SJ, et al:Probiotics for treating acute infectious diarrhoea. Cochrane Database Syst Rev:CD003048, 2010
5)Freedman SB, et al:Multicenter trial of a combination probiotic for children with gastroenteritis. N Engl J Med 379:2015-2026, 2018
6)Schnadower D, et al:Lactobacillus rhamnosus GG versus placebo for acute gastroenteritis in children. N Engl J Med 379:2002-2014, 2018
7)Huang Y-F, et al:Three-combination probiotics therapy in children with salmonella and rotavirus gastroenteritis. J Clin Gastroenterol 48:37-42, 2014
8)厚生労働省健康局結核感染症課:抗微生物薬適正使用の手引き 第一版,2017 http://www.mhlw.go.jp/stf/seisakunitsuite/bunya/0000120172.html(2019年3月14日閲覧)
9)山本舜悟,他:かぜ診療マニュアル—かぜとかぜにみえる重症疾患の見わけ方 第2版,日本医事新報社,2017